Cue Biopharma (CUE) Amortizatization of Intangibles (2020 - 2025)
Cue Biopharma's (CUE) quarterly Amortizatization of Intangibles came in at -$30000.0 in Q4 2025, down 150.0% quarter-over-quarter from -$12000.0 in Q3 2023.
Cue Biopharma (CUE) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends
Cue Biopharma has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting -$30000.0 for Q4 2025.
- Amortizatization of Intangibles for Q4 2025 came in at -$30000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$30000.0 (changed N/A YoY), and the FY2025 annual result was -$212000.0, changed N/A from the prior year.
- Amortizatization of Intangibles came in at -$30000.0 for Q4 2025 at Cue Biopharma, down from -$12000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.0 million in Q4 2021 to a low of -$220000.0 in Q4 2022.
- The 4-year median for Amortizatization of Intangibles is -$51500.0 (2023), against an average of $306330.9.
- Across the five-year window, Amortizatization of Intangibles jumped 45323.47% in 2021 and sank 107.24% in 2022, its largest moves.
- Cue Biopharma's Amortizatization of Intangibles stood at $3.0 million in 2021, then tumbled by 107.24% to -$220000.0 in 2022, then surged by 94.55% to -$12000.0 in 2023, then slumped by 150.0% to -$30000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at -$30000.0 (Q4 2025), -$12000.0 (Q3 2023), and -$73000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cue Biopharma | 581.16 Mn | 553.47 Mn | - | -30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30,000.00 |
| Dec 31, 2025 | -30,000.00 |
| Sep 30, 2023 | -12,000.00 |
| Sep 30, 2023 | -12,000.00 |
| Jun 30, 2023 | -73,000.00 |
| Jun 30, 2023 | -73,000.00 |
| Mar 31, 2023 | -149,000.00 |
| Mar 31, 2023 | -149,000.00 |
| Dec 31, 2022 | -220,000.00 |
| Dec 31, 2022 | -220,000.00 |
| Sep 30, 2022 | -101,000.00 |
| Sep 30, 2022 | -101,000.00 |
| Dec 31, 2021 | 3.04 Mn |
| Dec 31, 2021 | 3.04 Mn |
| Mar 31, 2021 | -5,000.00 |
| Mar 31, 2021 | -5,000.00 |
| Dec 31, 2020 | 6,694.00 |
| Dec 31, 2020 | 6,694.00 |
| Sep 30, 2020 | 22,000.00 |
| Sep 30, 2020 | 22,000.00 |